Crossmark

Fractionated stereotactic radiotherapy (fSRT) for symptomatic WHO grade 1 cavernous sinus meningiomas: long-term local control, clinical response, and toxicity outcomes

Crossref DOI link: https://doi.org/10.1007/s11060-026-05688-z

Published Online: 2026-06-30

Published Print: 2026-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shah, Ryan

Jain, Shray

Haldar, Nilanjan

Holt, Lauren A.

Walker, Robert L. III

Farrell, Christopher J.

Haldar, Debanjan

Evans, James J.

Alexander, Gregory S.

Shi, Wenyin
License Information

Text and Data Mining valid from 2026-06-30

Version of Record valid from 2026-06-30
More Information

Article History

Received: 15 May 2026

Accepted: 24 June 2026

First Online: 30 June 2026

Declarations

:

: This study was approved by the Institutional Review Board at Sidney Kimmel Cancer Center, with a waiver of informed consent.

: WS has received consulting fees from Varian, Brainlab, and Novocure. JJE has received consulting fees from Mizuho. No competing interests are declared by RS, SJ, NH, LAH, RLW, CJF, DH, or GSA.

Document is current

Any future updates will be listed below